international stem cell corp (ISCO) Details

International Stem Cell Corporation, a developmental stage biotechnology company, engages in the development and commercialization of therapeutic, biomedical, and cosmeceutical products in the United States and internationally. Its products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cells. The company develops cell types, such as liver cells to treat congenital and acquired liver diseases; islet cells for the treatment of diabetes; neuronal cells for the treatment of Parkinson’s disease and other central nervous system disorders; and three-dimensional eye structures to treat degenerative retinal diseases, corneal blindness, and to accelerate corneal healing. It also develops, manufactures, and markets cosmetic skin care products through a branded Website, professional channels, and distributors; and human cell culture products for use in pharmaceutical, academic, and government research organizations. The company’s human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human pooled liver cells for conducting screening tests on drug candidates; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines to study breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company was founded in 2001 and is headquartered in Carlsbad, California.

international stem cell corp (ISCO) Top Compensated Officers